See. 530.40 Safe Levels and Availability of Analytical Methods.
- In accordance with Sec. 530.22, the following safe levels for extralabel
use of an approved animal drug or human drug have been established: [Reserved]
- in accordance with Sec. 530.22, the following analytical methods have been
accepted by FDA: [Reserved]
See. 530.41 Drugs Prohibited For Extralable Use in Animals.
The following drugs are prohibited for extralabel animal and human drug uses
in food-producing animals:
(a) Chloramphenicol;
(b) Clenbuterol;
(c) Diethylstilbestrol (DES);
(d) Dimetridazole;
(e) Ipronidazole;
(f) Other nitroimidazoles;
(g) Furazolidone (except for approved topical use);
(h) Nitrofurazone (except for approved topical use); and
(i) Sulfonamide drugs in lactating dairy cattle (except approved use of sulfadimethoxine,
sul-fabromomethazine and sulfaethoxypyridazine).
NOTE TO READERS:
Section 530.21 of AMDUCA clearly states that the FDA Center for Veterinary
Medicine (CVM) may prohibit certain types of extra-label use in food
animals for a variety of reasons. A partial list of certain prohibited
drugs is contained within the text of AMDUCA. It is important to note
however, that additional drugs have been added to that list, specifically
the fluoroquinolones and glycopeptides. For a complete and current list of
drugs which may not be used in an extra-label fashion in food animals
please see Prohibited List and recent FARAD Digest, which is frequently updated.
Dated: October 22, 1996.
William B. Schultz, Deputy Commissioner for Policy.
[FR Doc. 96-28662 Filed 11-6-96; 8:45 am] BILLING CODE 4160-01-F